187 related articles for article (PubMed ID: 34852255)
1. Cost Efficiency Analysis for Spasticity Management Based on Physician Botulinum Toxin Prescribing Habits.
Kazerooni R; Howard I; Li X; Verduzco-Gutierrez M
Arch Phys Med Rehabil; 2022 Jun; 103(6):1205-1209. PubMed ID: 34852255
[TBL] [Abstract][Full Text] [Related]
2. Comparison of botulinum toxins for treatment of movement disorders: real-world utilization and cost analysis in a national Medicare population.
Kazerooni R; Watanabe JH
J Manag Care Spec Pharm; 2021 Apr; 27(4):478-487. PubMed ID: 33511895
[No Abstract] [Full Text] [Related]
3. Cost-minimization analysis in the treatment of spasticity in children with cerebral palsy with botulinum toxin type A: an observational, longitudinal, retrospective study.
Tapias G; García-Romero M; Crespo C; Cuesta M; Forné C; Pascual-Pascual SI
Farm Hosp; 2016 Sep; 40(5):412-26. PubMed ID: 27570991
[TBL] [Abstract][Full Text] [Related]
4. Regional disparities in botulinum toxin A (BoNT-A) therapy for spasticity in Sweden: budgetary consequences of closing the estimated treatment gap.
Ertzgaard P; Anhammer M; Forsmark A
Acta Neurol Scand; 2017 Mar; 135(3):366-372. PubMed ID: 27220381
[TBL] [Abstract][Full Text] [Related]
5. Botulinum Toxins Type A (Bont-A) in the Management of Lower Limb Spasticity in Children: A Systematic Literature Review and Bayesian Network Meta-analysis.
Guyot P; Kalyvas C; Mamane C; Danchenko N
J Child Neurol; 2019 Jun; 34(7):371-381. PubMed ID: 30803305
[TBL] [Abstract][Full Text] [Related]
6. Satisfaction with botulinum toxin treatment in post-stroke spasticity: results from two cross-sectional surveys (patients and physicians).
Bensmail D; Hanschmann A; Wissel J
J Med Econ; 2014 Sep; 17(9):618-25. PubMed ID: 24841450
[TBL] [Abstract][Full Text] [Related]
7. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness and impact on quality of life of abobotulinumtoxinA and onabotulinumtoxinA in the treatment of children with lower limb spasticity in Canada.
Johnston K; Danchenko N; Hansen R; Dinet J; Liovas A; Armstrong A; Bains S; Sullivan SD
J Med Econ; 2020 Jun; 23(6):631-640. PubMed ID: 31985313
[No Abstract] [Full Text] [Related]
9. The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystonia.
Danchenko N; Johnston KM; Whalen J
J Med Econ; 2022; 25(1):919-929. PubMed ID: 35730362
[TBL] [Abstract][Full Text] [Related]
10. Real-world differences in dosing and clinical utilization of OnabotulinumtoxinA and AbobotulinumtoxinA in the treatment of upper limb spasticity.
Bohart Z; Dashtipour K; Kim H; Schwartz M; Zuzek A; Singh R; Nelson M
Toxicon; 2024 Apr; 241():107678. PubMed ID: 38447766
[TBL] [Abstract][Full Text] [Related]
11. Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Costs Among Patients with Spasticity or Cervical Dystonia in the US.
Hull M; Anupindi VR; DeKoven M; He J; Bouchard J
Adv Ther; 2023 Sep; 40(9):3986-4003. PubMed ID: 37414904
[TBL] [Abstract][Full Text] [Related]
12. Effect of 3 Commercially Available Botulinum Toxin Neuromodulators on Facial Synkinesis: A Randomized Clinical Trial.
Thomas AJ; Larson MO; Braden S; Cannon RB; Ward PD
JAMA Facial Plast Surg; 2018 Mar; 20(2):141-147. PubMed ID: 28973094
[TBL] [Abstract][Full Text] [Related]
13. Time course response after single injection of botulinum toxin to treat spasticity after stroke: Systematic review with pharmacodynamic model-based meta-analysis.
Ojardias E; Ollier E; Lafaie L; Celarier T; Giraux P; Bertoletti L
Ann Phys Rehabil Med; 2022 May; 65(3):101579. PubMed ID: 34634514
[TBL] [Abstract][Full Text] [Related]
14. A Retrospective Cost Analysis of Patients Who Switched from OnabotulinumtoxinA to IncobotulinumtoxinA in a Private Neurology Practice.
Karschney VK; Greeley DR
Am Health Drug Benefits; 2020; 13(5):205-210. PubMed ID: 33343821
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial.
Marciniak C; McAllister P; Walker H; Brashear A; Edgley S; Deltombe T; Khatkova S; Banach M; Gul F; Vilain C; Picaut P; Grandoulier AS; Gracies JM;
PM R; 2017 Dec; 9(12):1181-1190. PubMed ID: 28625615
[TBL] [Abstract][Full Text] [Related]
16. The Italian real-life post-stroke spasticity survey: unmet needs in the management of spasticity with botulinum toxin type A.
Picelli A; Baricich A; Cisari C; Paolucci S; Smania N; Sandrini G
Funct Neurol; 2017; 32(2):89-96. PubMed ID: 28676142
[TBL] [Abstract][Full Text] [Related]
17. Cost-utility analysis of botulinum toxin type A products for the treatment of cervical dystonia.
Kazerooni R; Broadhead C
Am J Health Syst Pharm; 2015 Feb; 72(4):301-7. PubMed ID: 25631837
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Botulinum Toxin Injections on Spasticity and Motor Performance in Chronic Stroke with Spastic Hemiplegia.
Chen YT; Zhang C; Liu Y; Magat E; Verduzco-Gutierrez M; Francisco GE; Zhou P; Zhang Y; Li S
Toxins (Basel); 2020 Jul; 12(8):. PubMed ID: 32751970
[TBL] [Abstract][Full Text] [Related]
19. OnabotulinumtoxinA Reduces Temporal Pain Processing at Spinal Level in Patients with Lower Limb Spasticity.
De Icco R; Perrotta A; Berra E; Allena M; Alfonsi E; Tamburin S; Serrao M; Sandrini G; Tassorelli C
Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31226803
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of botulinum toxin type a in the treatment of post-stroke spasticity.
Ward A; Roberts G; Warner J; Gillard S
J Rehabil Med; 2005 Jul; 37(4):252-7. PubMed ID: 16024483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
